Dexa inj dosage and route in adult
dexamethasone injection dosage route of administration adults
| Route | Details |
|---|---|
| Intravenous (IV) | Most common in acute/hospital settings; rapid onset |
| Intramuscular (IM) | Alternative when IV access unavailable |
| Intra-articular | Joint injections for local inflammation |
| Intralesional | Skin/soft tissue lesions |
| Epidural | Spinal pain management |
| Soft tissue injection | Bursae, tendon sheaths |
| Indication | Dose | Route | Frequency |
|---|---|---|---|
| Anti-inflammatory / Immunosuppressive (general) | 0.5–9 mg/day | IV or IM | Divided doses |
| Cerebral edema | 10 mg initial, then 4 mg every 6 hours | IV | Taper over 5–7 days |
| Severe allergic reactions / Anaphylaxis adjunct | 8–10 mg | IV or IM | Single dose or as needed |
| Septic shock / Sepsis (refractory) | 6 mg/day | IV | Once daily × 10 days |
| COVID-19 (hospitalized, requiring O₂) | 6 mg once daily | IV or oral | × 10 days |
| Chemotherapy-induced nausea (CINV) | 8–20 mg | IV | 30 min before chemo |
| Postoperative nausea/vomiting (PONV) | 4–8 mg | IV | Single dose |
| Meningitis (bacterial) | 0.15 mg/kg every 6 hours | IV | × 4 days |
| Croup (laryngotracheobronchitis) | 0.6 mg/kg (max 10 mg) | IM or IV | Single dose |
| Intra-articular | 0.8–4 mg per joint | Intra-articular | Every 3–4 weeks PRN |
| Epidural | 4–10 mg per session | Epidural | 2–4 weeks minimum between injections |
Dexa inj 1cc ?
dexamethasone injection 1ml concentration mg per ml vial
| Vial Concentration | Dose in 1 mL |
|---|---|
| 4 mg/mL (most common) | 4 mg |
| 8 mg/2mL (4 mg/mL) | 4 mg |
| 10 mg/mL (high concentration) | 10 mg |
1 cc = 4 mg (using standard 4 mg/mL vial)
| Ordered Dose | Volume to Draw (4 mg/mL vial) |
|---|---|
| 4 mg | 1 mL (1 cc) |
| 8 mg | 2 mL |
| 10 mg | 2.5 mL |
| 6 mg (COVID/Sepsis) | 1.5 mL |
Inj dexa 1cc I.M and inj avil 1cc i.m ?
dexamethasone avil pheniramine injection intramuscular combination dosage
pheniramine maleate injection dose route adults
| Parameter | Detail |
|---|---|
| Concentration | 4 mg/mL (standard vial) |
| Dose in 1 cc | 4 mg |
| Route | Deep IM (gluteal / deltoid) |
| Onset | ~1–2 hours |
| Duration | 36–72 hours |
| Parameter | Detail |
|---|---|
| Concentration | 22.75 mg/mL (standard ampoule = 2 mL = 45.5 mg) |
| Dose in 1 cc | ~22.75 mg |
| Route | Deep IM |
| Onset | 15–30 minutes |
| Duration | 4–6 hours |
| Drug class | First-generation antihistamine (H1 blocker) |
Standard Avil ampoule is 2 mL (45.5 mg). If giving 1 cc, dose = ~22.75 mg.
| Point | Detail |
|---|---|
| Injection site | Gluteus medius (preferred) or deltoid |
| Needle | 21–23G, 1.5 inch for IM |
| Can be given same site? | Give at separate sites (do not mix in same syringe) |
| Position | Patient should rest for 15–30 min post-injection |
| Monitor for | Sedation (Avil), hyperglycemia (Dexa), BP changes |